カテゴリ： QYResearch, 世界, 医療/バイオ

複合化学療法の世界市場2025年：重量式自動調合装置、容量式自動調合装置

■ 英語タイトル：Global Compounding Chemotherapy Market Research Report 2025

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA7447）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA7447
■ 発行日：2025年3月
■ 調査対象地域：グローバル
■ 産業分野：医療
■ ページ数：98
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥417,600見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥626,400見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥835,200見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[複合化学療法の世界市場2025年：重量式自動調合装置、容量式自動調合装置]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査資料は複合化学療法のグローバル市場について調査・分析し、世界の複合化学療法市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（重量式自動調合装置、容量式自動調合装置）、用途別セグメント分析（乳がん、血液がん、前立腺がん、消化器がん、呼吸器/肺がん、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Braun Melsungen AG、Pfizer Inc.、Baxter、Grifols SA、The Metrix Company、Added Pharma、Equashield、Millers Pharmacy、Comecer S.P.A.、Omnicell、Icon group、Dedalus Group、Arxium、Sterline S.R.L.、Loccioniなどが含まれています。複合化学療法のグローバル市場は、2024年にXXX米ドル、2031年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。貿易戦争とロシア・ウクライナ戦争の影響は、複合化学療法市場規模を算出する際に考慮しました。

・複合化学療法市場の概要
- 複合化学療法の種類別セグメント
- 世界の複合化学療法市場規模：タイプ別分析（重量式自動調合装置、容量式自動調合装置）
- 複合化学療法の用途別セグメント
- 世界の複合化学療法市場規模：用途別分析（乳がん、血液がん、前立腺がん、消化器がん、呼吸器/肺がん、その他）
- 世界の複合化学療法市場規模予測（2020年-2031年）

・複合化学療法市場の成長トレンド
- 複合化学療法の地域別市場規模（2020年-2031年）
- 複合化学療法市場ダイナミクス
- 複合化学療法の業界動向
- 複合化学療法市場の成長ドライバ、課題、阻害要因

・主要企業別競争状況
- 企業別市場シェア
- 世界の主要企業、業界ランキング分析
- 市場への参入、M＆A動向

・種類別セグメント：重量式自動調合装置、容量式自動調合装置
- 世界の複合化学療法のタイプ別市場規模（2020年-2025年）
- 世界の複合化学療法のタイプ別市場規模（2024年-2029年）

・用途別セグメント：乳がん、血液がん、前立腺がん、消化器がん、呼吸器/肺がん、その他
- 世界の複合化学療法の用途別市場規模（2020年-2025年）
- 世界の複合化学療法の用途別市場規模（2024年-2029年）

・複合化学療法の地域別市場規模
- 北米の複合化学療法市場規模（2020年-2031年）
- 米国の複合化学療法市場規模（2020年-2031年）
- ヨーロッパの複合化学療法市場規模（2020年-2031年）
- アジア太平洋の複合化学療法市場規模（2020年-2031年）
- 中国の複合化学療法市場規模（2020年-2031年）
- 日本の複合化学療法市場規模（2020年-2031年）
- 韓国の複合化学療法市場規模（2020年-2031年）
- インドの複合化学療法市場規模（2020年-2031年）
- オーストラリアの複合化学療法市場規模（2020年-2031年）
- 中南米の複合化学療法市場規模（2020年-2031年）
- 中東・アフリカの複合化学療法市場規模（2020年-2031年）

・主要企業のプロファイル：企業情報、事業概要、売上、動向
Braun Melsungen AG、Pfizer Inc.、Baxter、Grifols SA、The Metrix Company、Added Pharma、Equashield、Millers Pharmacy、Comecer S.P.A.、Omnicell、Icon group、Dedalus Group、Arxium、Sterline S.R.L.、Loccioni

・アナリストの観点/結論

・調査手法と情報源

The compounding chemotherapy market is showing significant growth. Compounding of drugs makes them patient-specific which is the biggest advantage. Compounding chemotherapy can minimize the risk of underdose or overdose of drugs for a patient. Therefore, owing to its numerous advantages. 
Highlights
The global Compounding Chemotherapy market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of % during the forecast period 2025-2031. The influence of trade war and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Compounding Chemotherapy is estimated to increase from $ million in 2023 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Compounding Chemotherapy is estimated to increase from $ million in 2023 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Compounding Chemotherapy in Breast Cancer is estimated to increase from $ million in 2023 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The key global companies of Compounding Chemotherapy include Braun Melsungen AG, Pfizer Inc., Baxter, Grifols SA, The Metrix Company, Added Pharma, Equashield, Millers Pharmacy and Comecer S.P.A., etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Compounding Chemotherapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Compounding Chemotherapy.
The Compounding Chemotherapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Compounding Chemotherapy market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Compounding Chemotherapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Braun Melsungen AG
Pfizer Inc.
Baxter
Grifols SA
The Metrix Company
Added Pharma
Equashield
Millers Pharmacy
Comecer S.P.A.
Omnicell
Icon group
Dedalus Group
Arxium
Sterline S.R.L.
Loccioni
Segment by Type
Gravimetric Automated Compounding Device (Weight-Based)
Volumetric Automated Compounding Device (Volume-Based)
Segment by Application
Breast Cancer
Blood Cancer
Prostate Cancer
Gastrointestinal Cancer
Respiratory/Lung Cancer
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Compounding Chemotherapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Compounding Chemotherapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Gravimetric Automated Compounding Device (Weight-Based)
1.2.3 Volumetric Automated Compounding Device (Volume-Based)
1.3 Market by Application
1.3.1 Global Compounding Chemotherapy Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Breast Cancer
1.3.3 Blood Cancer
1.3.4 Prostate Cancer
1.3.5 Gastrointestinal Cancer
1.3.6 Respiratory/Lung Cancer
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Compounding Chemotherapy Market Perspective (2020-2031)
2.2 Compounding Chemotherapy Growth Trends by Region
2.2.1 Global Compounding Chemotherapy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Compounding Chemotherapy Historic Market Size by Region (2020-2025)
2.2.3 Compounding Chemotherapy Forecasted Market Size by Region (2026-2031)
2.3 Compounding Chemotherapy Market Dynamics
2.3.1 Compounding Chemotherapy Industry Trends
2.3.2 Compounding Chemotherapy Market Drivers
2.3.3 Compounding Chemotherapy Market Challenges
2.3.4 Compounding Chemotherapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Compounding Chemotherapy Players by Revenue
3.1.1 Global Top Compounding Chemotherapy Players by Revenue (2020-2025)
3.1.2 Global Compounding Chemotherapy Revenue Market Share by Players (2020-2025)
3.2 Global Compounding Chemotherapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Compounding Chemotherapy Revenue
3.4 Global Compounding Chemotherapy Market Concentration Ratio
3.4.1 Global Compounding Chemotherapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Compounding Chemotherapy Revenue in 2022
3.5 Compounding Chemotherapy Key Players Head office and Area Served
3.6 Key Players Compounding Chemotherapy Product Solution and Service
3.7 Date of Enter into Compounding Chemotherapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Compounding Chemotherapy Breakdown Data by Type
4.1 Global Compounding Chemotherapy Historic Market Size by Type (2020-2025)
4.2 Global Compounding Chemotherapy Forecasted Market Size by Type (2026-2031)
5 Compounding Chemotherapy Breakdown Data by Application
5.1 Global Compounding Chemotherapy Historic Market Size by Application (2020-2025)
5.2 Global Compounding Chemotherapy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Compounding Chemotherapy Market Size (2020-2031)
6.2 North America Compounding Chemotherapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Compounding Chemotherapy Market Size by Country (2020-2025)
6.4 North America Compounding Chemotherapy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Compounding Chemotherapy Market Size (2020-2031)
7.2 Europe Compounding Chemotherapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Compounding Chemotherapy Market Size by Country (2020-2025)
7.4 Europe Compounding Chemotherapy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Compounding Chemotherapy Market Size (2020-2031)
8.2 Asia-Pacific Compounding Chemotherapy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Compounding Chemotherapy Market Size by Region (2020-2025)
8.4 Asia-Pacific Compounding Chemotherapy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Compounding Chemotherapy Market Size (2020-2031)
9.2 Latin America Compounding Chemotherapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Compounding Chemotherapy Market Size by Country (2020-2025)
9.4 Latin America Compounding Chemotherapy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Compounding Chemotherapy Market Size (2020-2031)
10.2 Middle East & Africa Compounding Chemotherapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Compounding Chemotherapy Market Size by Country (2020-2025)
10.4 Middle East & Africa Compounding Chemotherapy Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Braun Melsungen AG
11.1.1 Braun Melsungen AG Company Detail
11.1.2 Braun Melsungen AG Business Overview
11.1.3 Braun Melsungen AG Compounding Chemotherapy Introduction
11.1.4 Braun Melsungen AG Revenue in Compounding Chemotherapy Business (2020-2025)
11.1.5 Braun Melsungen AG Recent Development
11.2 Pfizer Inc.
11.2.1 Pfizer Inc. Company Detail
11.2.2 Pfizer Inc. Business Overview
11.2.3 Pfizer Inc. Compounding Chemotherapy Introduction
11.2.4 Pfizer Inc. Revenue in Compounding Chemotherapy Business (2020-2025)
11.2.5 Pfizer Inc. Recent Development
11.3 Baxter
11.3.1 Baxter Company Detail
11.3.2 Baxter Business Overview
11.3.3 Baxter Compounding Chemotherapy Introduction
11.3.4 Baxter Revenue in Compounding Chemotherapy Business (2020-2025)
11.3.5 Baxter Recent Development
11.4 Grifols SA
11.4.1 Grifols SA Company Detail
11.4.2 Grifols SA Business Overview
11.4.3 Grifols SA Compounding Chemotherapy Introduction
11.4.4 Grifols SA Revenue in Compounding Chemotherapy Business (2020-2025)
11.4.5 Grifols SA Recent Development
11.5 The Metrix Company
11.5.1 The Metrix Company Company Detail
11.5.2 The Metrix Company Business Overview
11.5.3 The Metrix Company Compounding Chemotherapy Introduction
11.5.4 The Metrix Company Revenue in Compounding Chemotherapy Business (2020-2025)
11.5.5 The Metrix Company Recent Development
11.6 Added Pharma
11.6.1 Added Pharma Company Detail
11.6.2 Added Pharma Business Overview
11.6.3 Added Pharma Compounding Chemotherapy Introduction
11.6.4 Added Pharma Revenue in Compounding Chemotherapy Business (2020-2025)
11.6.5 Added Pharma Recent Development
11.7 Equashield
11.7.1 Equashield Company Detail
11.7.2 Equashield Business Overview
11.7.3 Equashield Compounding Chemotherapy Introduction
11.7.4 Equashield Revenue in Compounding Chemotherapy Business (2020-2025)
11.7.5 Equashield Recent Development
11.8 Millers Pharmacy
11.8.1 Millers Pharmacy Company Detail
11.8.2 Millers Pharmacy Business Overview
11.8.3 Millers Pharmacy Compounding Chemotherapy Introduction
11.8.4 Millers Pharmacy Revenue in Compounding Chemotherapy Business (2020-2025)
11.8.5 Millers Pharmacy Recent Development
11.9 Comecer S.P.A.
11.9.1 Comecer S.P.A. Company Detail
11.9.2 Comecer S.P.A. Business Overview
11.9.3 Comecer S.P.A. Compounding Chemotherapy Introduction
11.9.4 Comecer S.P.A. Revenue in Compounding Chemotherapy Business (2020-2025)
11.9.5 Comecer S.P.A. Recent Development
11.10 Omnicell
11.10.1 Omnicell Company Detail
11.10.2 Omnicell Business Overview
11.10.3 Omnicell Compounding Chemotherapy Introduction
11.10.4 Omnicell Revenue in Compounding Chemotherapy Business (2020-2025)
11.10.5 Omnicell Recent Development
11.11 Icon group
11.11.1 Icon group Company Detail
11.11.2 Icon group Business Overview
11.11.3 Icon group Compounding Chemotherapy Introduction
11.11.4 Icon group Revenue in Compounding Chemotherapy Business (2020-2025)
11.11.5 Icon group Recent Development
11.12 Dedalus Group
11.12.1 Dedalus Group Company Detail
11.12.2 Dedalus Group Business Overview
11.12.3 Dedalus Group Compounding Chemotherapy Introduction
11.12.4 Dedalus Group Revenue in Compounding Chemotherapy Business (2020-2025)
11.12.5 Dedalus Group Recent Development
11.13 Arxium
11.13.1 Arxium Company Detail
11.13.2 Arxium Business Overview
11.13.3 Arxium Compounding Chemotherapy Introduction
11.13.4 Arxium Revenue in Compounding Chemotherapy Business (2020-2025)
11.13.5 Arxium Recent Development
11.14 Sterline S.R.L.
11.14.1 Sterline S.R.L. Company Detail
11.14.2 Sterline S.R.L. Business Overview
11.14.3 Sterline S.R.L. Compounding Chemotherapy Introduction
11.14.4 Sterline S.R.L. Revenue in Compounding Chemotherapy Business (2020-2025)
11.14.5 Sterline S.R.L. Recent Development
11.15 Loccioni
11.15.1 Loccioni Company Detail
11.15.2 Loccioni Business Overview
11.15.3 Loccioni Compounding Chemotherapy Introduction
11.15.4 Loccioni Revenue in Compounding Chemotherapy Business (2020-2025)
11.15.5 Loccioni Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Compounding Chemotherapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Gravimetric Automated Compounding Device (Weight-Based)
Table 3. Key Players of Volumetric Automated Compounding Device (Volume-Based)
Table 4. Global Compounding Chemotherapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Compounding Chemotherapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Compounding Chemotherapy Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Compounding Chemotherapy Market Share by Region (2020-2025)
Table 8. Global Compounding Chemotherapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Compounding Chemotherapy Market Share by Region (2026-2031)
Table 10. Compounding Chemotherapy Market Trends
Table 11. Compounding Chemotherapy Market Drivers
Table 12. Compounding Chemotherapy Market Challenges
Table 13. Compounding Chemotherapy Market Restraints
Table 14. Global Compounding Chemotherapy Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Compounding Chemotherapy Market Share by Players (2020-2025)
Table 16. Global Top Compounding Chemotherapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Compounding Chemotherapy as of 2022)
Table 17. Ranking of Global Top Compounding Chemotherapy Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Compounding Chemotherapy Revenue (CR5 and HHI) & (2020-2025)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Compounding Chemotherapy Product Solution and Service
Table 21. Date of Enter into Compounding Chemotherapy Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Compounding Chemotherapy Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Compounding Chemotherapy Revenue Market Share by Type (2020-2025)
Table 25. Global Compounding Chemotherapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Compounding Chemotherapy Revenue Market Share by Type (2026-2031)
Table 27. Global Compounding Chemotherapy Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Compounding Chemotherapy Revenue Market Share by Application (2020-2025)
Table 29. Global Compounding Chemotherapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Compounding Chemotherapy Revenue Market Share by Application (2026-2031)
Table 31. North America Compounding Chemotherapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Compounding Chemotherapy Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Compounding Chemotherapy Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Compounding Chemotherapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Compounding Chemotherapy Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Compounding Chemotherapy Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Compounding Chemotherapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Compounding Chemotherapy Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Compounding Chemotherapy Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Compounding Chemotherapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Compounding Chemotherapy Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Compounding Chemotherapy Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Compounding Chemotherapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Compounding Chemotherapy Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Compounding Chemotherapy Market Size by Country (2026-2031) & (US$ Million)
Table 46. Braun Melsungen AG Company Detail
Table 47. Braun Melsungen AG Business Overview
Table 48. Braun Melsungen AG Compounding Chemotherapy Product
Table 49. Braun Melsungen AG Revenue in Compounding Chemotherapy Business (2020-2025) & (US$ Million)
Table 50. Braun Melsungen AG Recent Development
Table 51. Pfizer Inc. Company Detail
Table 52. Pfizer Inc. Business Overview
Table 53. Pfizer Inc. Compounding Chemotherapy Product
Table 54. Pfizer Inc. Revenue in Compounding Chemotherapy Business (2020-2025) & (US$ Million)
Table 55. Pfizer Inc. Recent Development
Table 56. Baxter Company Detail
Table 57. Baxter Business Overview
Table 58. Baxter Compounding Chemotherapy Product
Table 59. Baxter Revenue in Compounding Chemotherapy Business (2020-2025) & (US$ Million)
Table 60. Baxter Recent Development
Table 61. Grifols SA Company Detail
Table 62. Grifols SA Business Overview
Table 63. Grifols SA Compounding Chemotherapy Product
Table 64. Grifols SA Revenue in Compounding Chemotherapy Business (2020-2025) & (US$ Million)
Table 65. Grifols SA Recent Development
Table 66. The Metrix Company Company Detail
Table 67. The Metrix Company Business Overview
Table 68. The Metrix Company Compounding Chemotherapy Product
Table 69. The Metrix Company Revenue in Compounding Chemotherapy Business (2020-2025) & (US$ Million)
Table 70. The Metrix Company Recent Development
Table 71. Added Pharma Company Detail
Table 72. Added Pharma Business Overview
Table 73. Added Pharma Compounding Chemotherapy Product
Table 74. Added Pharma Revenue in Compounding Chemotherapy Business (2020-2025) & (US$ Million)
Table 75. Added Pharma Recent Development
Table 76. Equashield Company Detail
Table 77. Equashield Business Overview
Table 78. Equashield Compounding Chemotherapy Product
Table 79. Equashield Revenue in Compounding Chemotherapy Business (2020-2025) & (US$ Million)
Table 80. Equashield Recent Development
Table 81. Millers Pharmacy Company Detail
Table 82. Millers Pharmacy Business Overview
Table 83. Millers Pharmacy Compounding Chemotherapy Product
Table 84. Millers Pharmacy Revenue in Compounding Chemotherapy Business (2020-2025) & (US$ Million)
Table 85. Millers Pharmacy Recent Development
Table 86. Comecer S.P.A. Company Detail
Table 87. Comecer S.P.A. Business Overview
Table 88. Comecer S.P.A. Compounding Chemotherapy Product
Table 89. Comecer S.P.A. Revenue in Compounding Chemotherapy Business (2020-2025) & (US$ Million)
Table 90. Comecer S.P.A. Recent Development
Table 91. Omnicell Company Detail
Table 92. Omnicell Business Overview
Table 93. Omnicell Compounding Chemotherapy Product
Table 94. Omnicell Revenue in Compounding Chemotherapy Business (2020-2025) & (US$ Million)
Table 95. Omnicell Recent Development
Table 96. Icon group Company Detail
Table 97. Icon group Business Overview
Table 98. Icon group Compounding Chemotherapy Product
Table 99. Icon group Revenue in Compounding Chemotherapy Business (2020-2025) & (US$ Million)
Table 100. Icon group Recent Development
Table 101. Dedalus Group Company Detail
Table 102. Dedalus Group Business Overview
Table 103. Dedalus Group Compounding Chemotherapy Product
Table 104. Dedalus Group Revenue in Compounding Chemotherapy Business (2020-2025) & (US$ Million)
Table 105. Dedalus Group Recent Development
Table 106. Arxium Company Detail
Table 107. Arxium Business Overview
Table 108. Arxium Compounding Chemotherapy Product
Table 109. Arxium Revenue in Compounding Chemotherapy Business (2020-2025) & (US$ Million)
Table 110. Arxium Recent Development
Table 111. Sterline S.R.L. Company Detail
Table 112. Sterline S.R.L. Business Overview
Table 113. Sterline S.R.L. Compounding Chemotherapy Product
Table 114. Sterline S.R.L. Revenue in Compounding Chemotherapy Business (2020-2025) & (US$ Million)
Table 115. Sterline S.R.L. Recent Development
Table 116. Loccioni Company Detail
Table 117. Loccioni Business Overview
Table 118. Loccioni Compounding Chemotherapy Product
Table 119. Loccioni Revenue in Compounding Chemotherapy Business (2020-2025) & (US$ Million)
Table 120. Loccioni Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Compounding Chemotherapy Market Size Comparison by Type (2025-2031) & (US$ Million)
Figure 2. Global Compounding Chemotherapy Market Share by Type: 2022 VS 2029
Figure 3. Gravimetric Automated Compounding Device (Weight-Based) Features
Figure 4. Volumetric Automated Compounding Device (Volume-Based) Features
Figure 5. Global Compounding Chemotherapy Market Size Comparison by Application (2025-2031) & (US$ Million)
Figure 6. Global Compounding Chemotherapy Market Share by Application: 2022 VS 2029
Figure 7. Breast Cancer Case Studies
Figure 8. Blood Cancer Case Studies
Figure 9. Prostate Cancer Case Studies
Figure 10. Gastrointestinal Cancer Case Studies
Figure 11. Respiratory/Lung Cancer Case Studies
Figure 12. Others Case Studies
Figure 13. Compounding Chemotherapy Report Years Considered
Figure 14. Global Compounding Chemotherapy Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Compounding Chemotherapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Compounding Chemotherapy Market Share by Region: 2022 VS 2029
Figure 17. Global Compounding Chemotherapy Market Share by Players in 2024
Figure 18. Global Top Compounding Chemotherapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Compounding Chemotherapy as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Compounding Chemotherapy Revenue in 2024
Figure 20. North America Compounding Chemotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Compounding Chemotherapy Market Share by Country (2020-2031)
Figure 22. United States Compounding Chemotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Compounding Chemotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Compounding Chemotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Compounding Chemotherapy Market Share by Country (2020-2031)
Figure 26. Germany Compounding Chemotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Compounding Chemotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Compounding Chemotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Compounding Chemotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Compounding Chemotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Compounding Chemotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Compounding Chemotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Compounding Chemotherapy Market Share by Region (2020-2031)
Figure 34. China Compounding Chemotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Compounding Chemotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Compounding Chemotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Compounding Chemotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Compounding Chemotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Compounding Chemotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Compounding Chemotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Compounding Chemotherapy Market Share by Country (2020-2031)
Figure 42. Mexico Compounding Chemotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Compounding Chemotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Compounding Chemotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Compounding Chemotherapy Market Share by Country (2020-2031)
Figure 46. Turkey Compounding Chemotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Compounding Chemotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Braun Melsungen AG Revenue Growth Rate in Compounding Chemotherapy Business (2020-2025)
Figure 49. Pfizer Inc. Revenue Growth Rate in Compounding Chemotherapy Business (2020-2025)
Figure 50. Baxter Revenue Growth Rate in Compounding Chemotherapy Business (2020-2025)
Figure 51. Grifols SA Revenue Growth Rate in Compounding Chemotherapy Business (2020-2025)
Figure 52. The Metrix Company Revenue Growth Rate in Compounding Chemotherapy Business (2020-2025)
Figure 53. Added Pharma Revenue Growth Rate in Compounding Chemotherapy Business (2020-2025)
Figure 54. Equashield Revenue Growth Rate in Compounding Chemotherapy Business (2020-2025)
Figure 55. Millers Pharmacy Revenue Growth Rate in Compounding Chemotherapy Business (2020-2025)
Figure 56. Comecer S.P.A. Revenue Growth Rate in Compounding Chemotherapy Business (2020-2025)
Figure 57. Omnicell Revenue Growth Rate in Compounding Chemotherapy Business (2020-2025)
Figure 58. Icon group Revenue Growth Rate in Compounding Chemotherapy Business (2020-2025)
Figure 59. Dedalus Group Revenue Growth Rate in Compounding Chemotherapy Business (2020-2025)
Figure 60. Arxium Revenue Growth Rate in Compounding Chemotherapy Business (2020-2025)
Figure 61. Sterline S.R.L. Revenue Growth Rate in Compounding Chemotherapy Business (2020-2025)
Figure 62. Loccioni Revenue Growth Rate in Compounding Chemotherapy Business (2020-2025)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed

※参考情報

複合化学療法とは、がん治療において複数の化学療法薬を組み合わせて使用する治療法のことを指します。単独の薬剤に比べて、複数の薬剤を同時に使うことで効果を高め、がん細胞の増殖を抑えることを目的としています。この治療法は、がんの種類や進行度、患者の健康状態に応じて選択されます。

複合化学療法の主な特徴は、その多様性と柔軟性です。具体的には、治療に使用される薬剤の組み合わせや投与スケジュールが患者ごとに異なるため、個々の症例に応じた最適な治療が可能になります。また、複合化学療法は異なる作用機序を持つ薬剤を組み合わせることによって、がん細胞に対する攻撃の強度を増すことが期待されます。これにより、薬剤耐性を持つがん細胞に対しても効果を発揮し、治療の成功率を向上させることが可能です。

複合化学療法にはいくつかの種類があります。一般的に、薬剤の選定はがんの種類やステージによって異なります。たとえば、白血病やリンパ腫では、特定の種類の抗がん剤の組み合わせが用いられます。更に、乳がんや大腸がんなどの固形腫瘍の場合、化学療法薬に加えてホルモン療法や分子標的治療を併用することもあります。これにより、複数の異なるメカニズムからがん細胞を攻撃することができ、再発のリスクを低減させる効果が期待されます。

また、複合化学療法は、単独の薬剤では効果が薄い場合や、耐性が生じている場合に特に有効です。例えば、最初の治療でがんが縮小したが、再び成長を始めた場合、異なる作用機序を持つ薬剤を組み合わせることで再度効果を発揮させることが可能になります。これにより、患者の治療選択肢が広がるとともに、治療のつらさを軽減することにも繋がります。

複合化学療法においては、治療を行う際に特に注意が必要です。複数の薬剤を組み合わせることで、相互作用や副作用が増加する可能性があります。そのため、医師は患者の全体的な健康状況や他の疾患、服用中の薬剤について十分に評価し、適切な治療計画を立てる必要があります。副作用としては、吐き気、倦怠感、血液の減少（貧血や白血球減少）、感染症のリスク増加などがあり、そうした副作用を軽減するための対策も重要です。

また、最近では、個別化医療の発展により、患者の遺伝的情報を基にした治療法の選定が進んでいます。これにより、特定の薬剤が効きやすい遺伝的特徴を持つ患者に対して、効果的な薬剤の組み合わせを提案することが可能となり、複合化学療法の効果を更に高める一助となります。

複合化学療法の関連技術としては、放射線療法や免疫療法が挙げられます。放射線療法は、がん細胞に特異的に放射線を照射することで細胞を破壊する治療法であり、化学療法との併用により、がん細胞に対する攻撃力を増強することができます。一方、免疫療法は、患者自身の免疫システムを利用してがん細胞を攻撃する治療法であり、これも化学療法と併用することで、治療効果を引き出すアプローチが試みられています。

実際の治療の場面では、複合化学療法は標準治療として広く用いられており、近年の研究によってその効果が証明されています。多くのがんにおいて、複合的な治療アプローチが患者の生存率を向上させ、生活の質を向上させていることが明らかになっています。また、研究の進展に伴い、新たな薬剤や治療法が開発され続けており、今後も複合化学療法の可能性は拡大していくと考えられます。

患者の生活の質を考慮した治療を行うためには、専門の医療チームが連携し、患者とその家族に対して十分な情報提供と支援を行うことが求められます。複合化学療法は効果的な治療法である一方、その費用や副作用の管理が重要な課題でもあります。そのため、治療決定においては、医師と患者が十分なコミュニケーションを図り、個々の状況に最適な選択をすることが不可欠です。

複合化学療法は、がん治療の選択肢の一つとして非常に重要な役割を果たしています。その知識と技術が進化することで、今後もより多くの患者に対する治療効果が向上し、がんに対する戦いにおいて新たな希望をもたらすことが期待されています。


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 血液腫瘍治療の世界市場2025年：化学療法、標的療法、免疫療法、その他
  • うつ病治療薬の世界市場2025年：SSRI、SNRI、その他
  • 免疫サポート成分の世界市場2025年：ビタミンC、ビタミンE、その他ビタミン、ベータグルカン、カロテノイド、フィトステロール、オメガ3脂肪酸
  • 地上波以外IoTの世界市場2025年：ハードウェア、ソフトウェア、サービス
  • 放射性医薬品療法の世界市場2025年：アクチニウム-225、ルテチウム-177、ラジウム-223、ホルミウム-166、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA7447 )"複合化学療法の世界市場2025年：重量式自動調合装置、容量式自動調合装置" (英文：Global Compounding Chemotherapy Market Research Report 2025)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。